SCHEMBL6833790

SCHEMBL6833790

NC(=O)c1nc2ccccc2c2c1nc(-c1ccccc1)n2CCC1CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 2/20 0.42
PIM1 P11309 1/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
PTGER4 P35408 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
NPY1R P25929 1/20 0.38
PDPK1 O15530 1/20 0.37
CDK2 P24941 1/20 0.37
HTR4 Q13639 1/20 0.37
MERTK Q12866 1/20 0.36
PDE6D O43924 1/20 0.36
TLR7 Q9NYK1 2/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36
AURKA O14965 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838636 0.92 PTGER4 (0.41) ACP1PIM1PIM3PIM2PTGER4
SCHEMBL6929281 0.86 NPY1R (0.40) ACP1PTGER4HDAC1HDAC8HDAC6
Trifluoroacetic Acid SCHEMBL6927056 0.86 TLR7 (0.45) TLR7
SCHEMBL6838078 0.85 MERTK (0.43) ACP1NPY1RHTR4MERTKPDE6D
SCHEMBL7489996 0.85 NPY1R (0.40) ACP1NPY1RHTR4MERTKPDE6D
SCHEMBL6928192 0.85 HTR4 (0.42) ACP1PTGER4NPY1RHTR4MERTK
SCHEMBL6925914 0.84 NPY1R (0.44) ACP1NPY1RHTR4MERTKPDE6D
SCHEMBL6838557 0.83 MAOB (0.39) ACP1NPY1RHTR4MERTKPDE6D
Hydrochloric Acid SCHEMBL6923145 0.83 NPY1R (0.43) ACP1NPY1RHTR4MERTKPDE6D
Fumaric Acid SCHEMBL729085 0.82 HDAC1 (0.41) ACP1PIM1PIM3PIM2PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 ACP1 490/4885PIM1 261/4885PIM3 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.